For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Blog
Trump’s State of the Union: A closer look at the claims
Last night, President Trump delivered a State of the Union address filled with optimism, applause lines, and bold claims about the country’s direction. There…
Search Posts
Products
A Real Bill Of Rights For Passengers
Well, the sure signs of summer are upon us once again. The temperature is rising, there are tourists everywhere, and things are slowing down to…
News Release
CEI Weighs In On Drycleaning Zoning Proposal
<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> TESTIMONY OF THE COMPETITIVE ENTERPRISE INSTITUTE…
News Release
CEI Comments Before FDA on Bioengineered Foods
COMMENTS OF THE COMMENTS OF THE COMPETITIVE ENTERPRISE INSTITUTE TO THE FOOD AND DRUG ADMINISTRATION REGARDING THE…
Products
Hope, Not Hype, in the Golden Grains
Two years ago, practically no one had ever heard of Ingo Potrykus Two years ago, practically no one had ever heard of…
Op-Eds
Designer Jeans from Designer Genes: Henry Miller National Post Op-Ed
California Gov Published February 12, 2001 The National Post (Canada) Self-styled environmentalists have been virtually unanimous in opposing biotechnology,…
Op-Eds
FDA Fails to Give Olestra Fair Weight: Henry Miller LA Times Op-Ed
Published in the Los Angeles Times Published in the Los Angeles Times February 4, 2001 The sad…